CClinicalTrials.gg
CompletedNCT07161648Updated Aug 26, 2026

Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance

An interventional study of neuromuscular electrical stimulation in Fat Metabolism, sponsored by Colorado State University. Completed at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Colorado State University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Oct 2024, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The study will find out if 100 minutes of electrical stimulation of muscle prevents the unfavorable consequence of insufficient exercise.

Read the detailed description

Exercise resistance is characterized by the absence of exercise induced improvements in fat metabolism following a meal, and results from prolonged sedentary behavior between successive workouts (i.e. 2+ sedentary days between exercise bouts). The suggested energy expenditure threshold for avoiding exercise resistance is the equivalent of walking \~8,500 steps/day. However, population data indicate that the typical adult in the US only walks 5,000 steps/day (i.e. 3,500 steps below the threshold). Neuromuscular Electrical Stimulation (NMES) evokes skeletal muscle contractions and increases energy expenditure. The hypothesis to be explored in this current proposal is: NMES will prevent exercise resistance. The plan is to induce exercise resistance via short-term abstention from activity other than exercise, and then on a separate occasion, use NMES to prevent exercise resistance (i.e. the short-term abstention from exercise will be "replaced" with NMES).

02

Conditions studied

  • Fat Metabolism

Browse trials for

Keywords

  • exercise
  • exercise resistance
  • electrical stimulation
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's enrollment of 24 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

Colorado State University is the lead sponsor of 112 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Regularly active (more than 30 minutes of exercise per day, 3 days per week, over the previous 12 months)
  • Ability to complete at least one hour of treadmill exercise (i.e. jogging/running),
  • Willing to abstain from caffeine and alcohol for 24-hours prior to three different study visits
  • Competency in English

Exclusion criteria

Exclusion Criteria:

  • Current or previous injuries that may hinder a participant's ability to exercise on a treadmill
  • A history of cardiopulmonary disorder that may be contra-indicative to treadmill exercise
  • Current use of cardio-pulmonary medication to treat a cardio-pulmonary condition
  • Currently breastfeeding
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • No intervention
    Establishing the normal benefit of exercise

    Study participants will complete treadmill exercise. During the same day, they will walk a minimum of 8,500 steps. The next day, fat oxidation will be measured after eating a high-fat meal.

  • No intervention
    Demonstrating exercise resistance

    Study participants will complete treadmill exercise. They will walk no more than 5,000 steps on the same day. The next day, fat oxidation will be measured after eating a high-fat meal.

  • Experimental
    Trying to prevent exercise resistance

    Study participants will complete treadmill exercise. They will walk no more than 5,000 steps on the same day. They will receive 100 minutes of neuromuscular electrical stimulation. The next day, fat oxidation will be measured after eating a high-fat meal.

    Other: neuromuscular electrical stimulation

Interventions

  • Otherneuromuscular electrical stimulation

    The study participants will engage in 100-minutes of neuromuscular electrical stimulation (NMES). NMES pads are sticky pieces of plastic, similar in size to a 25-cent coin. The pads will be placed on the bellies of thigh muscles (the vastus lateralis, vastus medialis), and calf muscles (the long and short head of the gastrocnemius). These skeletal muscles are selected due to their size (thereby promoting a bigger increase for metabolic rate compared with a small muscle), because they are relatively superficial, and because previous published studies of NMES used these anatomical locations.

06

What researchers measure

Primary outcomes

  1. Fat oxidation

    Circulating triglyceride concentration after eating a high fat meal.

    Time frame: Blood will be sampled and triglyceride concentration measured. Study participants will eat a meal. Blood will be sampled and triglyceride concentration measured every 30-minutes for 4 hours.

07

Study locations

1 site
  • Colorado State University
    Fort Collins, Colorado 80523, United States
08

References and documents

Individual participant data

Plan to share: No — Group descriptive statistics (e.g. average and standard deviation) will be shared.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07161648
Lead sponsor
Colorado State University
Responsible party
Christopher Bell (Associate Prof, Colorado State University) — Principal investigator
First posted
Sep 8, 2025
Start date
Oct 17, 2024
Primary completion
Feb 19, 2026
Completion
May 11, 2026
Last update
Aug 26, 2026

Study contacts

Christopher Bell, Ph.D.
principal investigator · Colorado State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion